Clavis Pharma ASA
Records under this name other than patents Clavis Pharma ASA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Clavis Pharma ASA
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,722,041 | Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof Lapsed on the fee record Ended May 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 13, 2026 | From the USPTO record |
| US 8,349,834 | Dioxolane derivates for the treatment of cancer Lapsed on the fee record Ended Jan 8, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 8, 2021 | From the USPTO record |
| US 9,428,540 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents Lapsed on the fee record Ended Aug 30, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2020 | From the USPTO record |
| US 6,384,019 | Gemcitabine derivatives Term ended Term ended Sep 15, 2019 · From the USPTO record | Term ended | Term ended Sep 15, 2019 | From the USPTO record |
| US 8,912,162 | Parenteral formulations of elacytarabine derivatives Lapsed on the fee record Ended Dec 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 16, 2018 | From the USPTO record |
| US 6,316,425 | Therapeutic agents Term ended Term ended May 26, 2018 · From the USPTO record | Term ended | Term ended May 26, 2018 | From the USPTO record |
| US 8,399,420 | Azacytidine analogues and uses thereof Lapsed on the fee record Ended Mar 19, 2017 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2017 | From the USPTO record |
| US 6,762,175 | Fatty acid derivatives Term ended Term ended Jan 24, 2017 · From the USPTO record | Term ended | Term ended Jan 24, 2017 | From the USPTO record |
| US 6,335,322 | Therapeutic agents Lapsed on the fee record Ended Jan 1, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 1, 2014 | From the USPTO record |